Therapeutic strategies to combat neointimal hyperplasia in vascular grafts

References

• Imparato AM, Bracco A, Kim GE, Zeff R. Intimal and neointimal fibrous proliferation causing failure of arterial reconstructions. Surgery 72(6), 1007–1017 (1972).
   PubMed Web of Science ®Google Scholar
• Nguyen LL, Moneta GL, Conte MS, Bandyk DF, Clowes AW, Seely BL; PREVENT III Investigators. Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J. Vasc. Surg. 44(5), 977–983; discussion 983 (2006).
   Google Scholar
• Muto A, Model L, Ziegler K, Eghbalieh SD, Dardik A. Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies. Circ. J. 74(8), 1501–1512 (2010).
   Google Scholar
• Muto A, Fitzgerald TN, Pimiento JM et al. Smooth muscle cell signal transduction: implications of vascular biology for vascular surgeons. J. Vasc. Surg. 45(Suppl. A), A15–A24 (2007).
   Google Scholar
• Christiansen JF, Hartwig D, Bechtel JF et al. Diseased vein grafts express elevated inflammatory cytokine levels compared with atherosclerotic coronary arteries. Ann. Thorac. Surg. 77(5), 1575–1579 (2004).
   Google Scholar
• Moreno K, Murray-Wijelath J, Yagi M et al. Circulating inflammatory cells are associated with vein graft stenosis. J. Vasc. Surg. 54(4), 1124–1130 (2011).
   Google Scholar
• Kenagy RD, Fukai N, Min SK, Jalikis F, Kohler TR, Clowes AW. Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis. J. Vasc. Surg. 49(5), 1282–1288 (2009).
   PubMed Web of Science ®Google Scholar
• Roy-Chaudhury P, Wang Y, Krishnamoorthy M et al. Cellular phenotypes in human stenotic lesions from haemodialysis vascular access. Nephrol. Dial. Transplant. 24(9), 2786–2791 (2009).
   PubMed Web of Science ®Google Scholar
• Sata M, Saiura A, Kunisato A et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8(4), 403–409 (2002).
   PubMed Web of Science ®Google Scholar
• Gerthoffer WT. Mechanisms of vascular smooth muscle cell migration. Circ. Res. 100(5), 607–621 (2007).
   PubMed Web of Science ®Google Scholar
• Roy-Chaudhury P, Kelly BS, Miller MA et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int. 59(6), 2325–2334 (2001).
   PubMed Web of Science ®Google Scholar
• Lee T, Roy-Chaudhury P. Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv. Chronic Kidney Dis. 16(5), 329–338 (2009).
   PubMed Web of Science ®Google Scholar
• Roy-Chaudhury P, Arend L, Zhang J et al. Neointimal hyperplasia in early arteriovenous fistula failure. Am. J. Kidney Dis. 50(5), 782–790 (2007).
   PubMed Web of Science ®Google Scholar
• Mehta RI, Mukherjee AK, Patterson TD, Fishbein MC. Pathology of explanted polytetrafluoroethylene vascular grafts. Cardiovasc. Pathol. 20(4), 213–221 (2011).
   Google Scholar
• Schanzer A, Hevelone N, Owens CD et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J. Vasc. Surg. 46(6), 1180–1190; discussion 1190 (2007).
   Google Scholar
• McCabe M, Cunningham GJ, Wyatt AP, Rothnie NG, Taylor GW. A histological and histochemical examination of autogenous vein grafts. Br. J. Surg. 54(2), 147–155 (1967).
   PubMed Web of Science ®Google Scholar
• Wyatt AP, Taylor GW. Vein grafts: changes in the endothelium of autogenous free vein grafts used as arterial replacements. Br. J. Surg. 53(11), 943–947 (1966).
   Google Scholar
• Mitra AK, Gangahar DM, Agrawal DK. Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol. Cell Biol. 84(2), 115–124 (2006).
   PubMed Web of Science ®Google Scholar
• Li L, Terry CM, Shiu YT, Cheung AK. Neointimal hyperplasia associated with synthetic hemodialysis grafts. Kidney Int. 74(10), 1247–1261 (2008).
   Google Scholar
• LoGerfo FW, Corson JD, Mannick JA. Improved results with femoropopliteal vein grafts for limb salvage. Arch. Surg. 112(5), 567–570 (1977).
   Google Scholar
• McGeachie JK, Meagher S, Prendergast FJ. Vein-to-artery grafts: the long-term development of neo-intimal hyperplasia and its relationship to vasa vasorum and sympathetic innervation. Aust. NZ J. Surg. 59(1), 59–65 (1989).
   Google Scholar
• Ramos JR, Berger K, Mansfield PB, Sauvage LR. Histologic fate and endothelial changes of distended and nondistended vein grafts. Ann. Surg. 183(3), 205–228 (1976).
   PubMed Web of Science ®Google Scholar
• Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 90(3), 251–262 (2002).
   PubMed Web of Science ®Google Scholar
• Davies PF, Polacek DC, Shi C, Helmke BP. The convergence of haemodynamics, genomics, and endothelial structure in studies of the focal origin of atherosclerosis. Biorheology 39(3-4), 299–306 (2002).
   Google Scholar
• Loth F, Jones SA, Zarins CK et al. Relative contribution of wall shear stress and injury in experimental intimal thickening at PTFE end-to-side arterial anastomoses. J. Biomech. Eng. 124(1), 44–51 (2002).
   PubMed Web of Science ®Google Scholar
• Ma YH, Ling S, Ives HE. Mechanical strain increases PDGF-B and PDGF β receptor expression in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 265(2), 606–610 (1999).
   Google Scholar
• Chen AH, Gortler DS, Kilaru S, Araim O, Frangos SG, Sumpio BE. Cyclic strain activates the pro-survival Akt protein kinase in bovine aortic smooth muscle cells. Surgery 130(2), 378–381 (2001).
   Google Scholar
• Li C, Hu Y, Mayr M, Xu Q. Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac–MAPK pathways. J. Biol. Chem. 274(36), 25273–25280 (1999).
   PubMed Web of Science ®Google Scholar
• Zhang BC, Zhou ZW, Li XK, Xu YW. PI-3K/AKT signal pathway modulates vascular smooth muscle cells migration under cyclic mechanical strain. VASA 40(2), 109–116 (2011).
   Google Scholar
• Swedberg SH, Brown BG, Sigley R, Wight TN, Gordon D, Nicholls SC. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation 80(6), 1726–1736 (1989).
   Google Scholar
• Wasse H, Rivera AA, Huang R et al. Increased plasma chymase concentration and mast cell chymase expression in venous neointimal lesions of patients with CKD and ESRD. Semin. Dial. 24(6), 688–693 (2011).
   Google Scholar
• Lee T, Chauhan V, Krishnamoorthy M et al. Severe venous neointimal hyperplasia prior to dialysis access surgery. Nephrol. Dial. Transplant. 26(7), 2264–2270 (2011).
   Google Scholar
• Roy-Chaudhury P, Sukhatme VP, Cheung AK. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J. Am. Soc. Nephrol. 17(4), 1112–1127 (2006).
   PubMed Web of Science ®Google Scholar
• Nassar GM. Endovascular management of the ‘failing to mature’ arteriovenous fistula. Tech. Vasc. Interv. Radiol. 11(3), 175–180 (2008).
   Google Scholar
• Carter A, Murphy MO, Halka AT et al. The natural history of stenoses within lower limb arterial bypass grafts using a graft surveillance program. Ann. Vasc. Surg. 21(6), 695–703 (2007).
   Google Scholar
• Tinder CN, Chavanpun JP, Bandyk DF et al. Efficacy of duplex ultrasound surveillance after infrainguinal vein bypass may be enhanced by identification of characteristics predictive of graft stenosis development. J. Vasc. Surg. 48(3), 613–618 (2008).
   Google Scholar
• Grüntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N. Engl. J. Med. 301(2), 61–68 (1979).
   PubMed Web of Science ®Google Scholar
• Douglas JS Jr, Gruentzig AR, King SB 3rd et al. Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery. J. Am. Coll. Cardiol. 2(4), 745–754 (1983).
   PubMed Web of Science ®Google Scholar
• Waller BF, Orr CM, Van Tassel J et al. Coronary artery and saphenous vein graft remodeling: a review of histologic findings after various interventional procedures –part V. Clin. Cardiol. 20(1), 67–74 (1997).
   Google Scholar
• Saber RS, Edwards WD, Bailey KR, McGovern TW, Schwartz RS, Holmes DR Jr. Coronary embolization after balloon angioplasty or thrombolytic therapy: an autopsy study of 32 cases. J. Am. Coll. Cardiol. 22(5), 1283–1288 (1993).
   PubMed Web of Science ®Google Scholar
• de Feyter PJ, van Suylen RJ, de Jaegere PP, Topol EJ, Serruys PW. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J. Am. Coll. Cardiol. 21(7), 1539–1549 (1993).
   PubMed Web of Science ®Google Scholar
• Avino AJ, Bandyk DF, Gonsalves AJ et al. Surgical and endovascular intervention for infrainguinal vein graft stenosis. J. Vasc. Surg. 29(1), 60–70; discussion 70 (1999).
   Google Scholar
• Schneider PA, Caps MT, Nelken N. Infrainguinal vein graft stenosis: cutting balloon angioplasty as the first-line treatment of choice. J. Vasc. Surg. 47(5), 960–966; discussion 966 (2008).
   Google Scholar
• Berceli SA, Hevelone ND, Lipsitz SR et al. Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. J. Vasc. Surg. 46(6), 1173–1179 (2007).
   PubMedGoogle Scholar
• Keeley EC, Velez CA, O’Neill WW, Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J. Am. Coll. Cardiol. 38(3), 659–665 (2001).
   PubMed Web of Science ®Google Scholar
• de Jaegere PP, van Domburg RT, Feyter PJ et al. Long-term clinical outcome after stent implantation in saphenous vein grafts. J. Am. Coll. Cardiol. 28(1), 89–96 (1996).
   Google Scholar
• Brilakis ES, Lichtenwalter C, de Lemos JA et al. A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial. J. Am. Coll. Cardiol. 53(11), 919–928 (2009).
   PubMedGoogle Scholar
• Vermeersch P, Agostoni P, Verheye S et al.; DELAYED RRISC (Death and Events at Long-term follow-up AnalYsis: Extended Duration of the Reduction of Restenosis In Saphenous vein grafts with Cypher stent) Investigators. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial. J. Am. Coll. Cardiol. 50(3), 261–267 (2007).
   PubMed Web of Science ®Google Scholar
• Vikram R, Ross RA, Bhat R et al. Cutting balloon angioplasty versus standard balloon angioplasty for failing infra-inguinal vein grafts: comparative study of short- and mid-term primary patency rates. Cardiovasc. Intervent. Radiol. 30(4), 607–610 (2007).
   Google Scholar
• Nguyen LL, Conte MS, Menard MT et al. Infrainguinal vein bypass graft revision: factors affecting long-term outcome. J. Vasc. Surg. 40(5), 916–923 (2004).
   PubMed Web of Science ®Google Scholar
• Landry GJ, Moneta GL, Taylor LM Jr, Edwards JM, Yeager RA, Porter JM. Long-term outcome of revised lower-extremity bypass grafts. J. Vasc. Surg. 35(1), 56–62; discussion 62 (2002).
   Google Scholar
• Bandyk DF, Bergamini TM, Towne JB, Schmitt DD, Seabrook GR. Durability of vein graft revision: the outcome of secondary procedures. J. Vasc. Surg. 13(2), 200–208; discussion 209 (1991).
   Google Scholar
• Waksman R, Ajani AE, White RL et al. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N. Engl. J. Med. 346(16), 1194–1199 (2002).
   PubMed Web of Science ®Google Scholar
• Holmes DR Jr, Teirstein PS, Satler L et al.; SISR Investigators. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial. JACC. Cardiovasc. Interv. 1(4), 439–448 (2008).
   Google Scholar
• Misra S, Bonan R, Pflederer T, Roy-Chaudhury P; BRAVO I Investigators. BRAVO I: a pilot study of vascular brachytherapy in polytetrafluoroethylene dialysis access grafts. Kidney Int. 70(11), 2006–2013 (2006).
   Google Scholar
• Hansrani M, Overbeck K, Smout J, Stansby G. Intravascular brachytherapy for peripheral vascular disease. Cochrane Database Syst. Rev. 4, CD003504 (2002).
   Google Scholar
• Diehm N, Silvestro A, Do DD et al. Endovascular brachytherapy after femoropopliteal balloon angioplasty fails to show robust clinical benefit over time. J. Endovasc. Ther. 12(6), 723–730 (2005).
   Google Scholar
• Griffiths GD, Nagy J, Black D, Stonebridge PA. Randomized clinical trial of distal anastomotic interposition vein cuff in infrainguinal polytetrafluoroethylene bypass grafting. Br. J. Surg. 91(5), 560–562 (2004).
   Google Scholar
• Trubel W, Schima H, Czerny M, Perktold K, Schimek MG, Polterauer P. Experimental comparison of four methods of end-to-side anastomosis with expanded polytetrafluoroethylene. Br. J. Surg. 91(2), 159–167 (2004).
   PubMed Web of Science ®Google Scholar
• Gentile AT, Mills JL, Gooden MA et al. Vein patching reduces neointimal thickening associated with prosthetic graft implantation. Am. J. Surg. 176(6), 601–607 (1998).
   PubMed Web of Science ®Google Scholar
• Yeung KK, Mills JL Sr, Hughes JD, Berman SS, Gentile AT, Westerband A. Improved patency of infrainguinal polytetrafluoroethylene bypass grafts using a distal Taylor vein patch. Am. J. Surg. 182(6), 578–583 (2001).
   Google Scholar
• Tsoulfas G, Hertl M, Ko DS et al. Long-term outcome of a cuffed expanded PTFE graft for hemodialysis vascular access. World J. Surg. 32(8), 1827–1831 (2008).
   Google Scholar
• Panneton JM, Hollier LH, Hofer JM. Multicenter randomized prospective trial comparing a pre-cuffed polytetrafluoroethylene graft to a vein cuffed polytetrafluoroethylene graft for infragenicular arterial bypass. Ann. Vasc. Surg. 18(2), 199–206 (2004).
   PubMed Web of Science ®Google Scholar
• Gulkarov I, Malik R, Yakubov R et al. Early results for below-knee bypasses using Distaflo. Vasc. Endovascular Surg. 42(6), 561–566 (2008).
   Google Scholar
• Zilla P, Human P, Wolf M et al. Constrictive external nitinol meshes inhibit vein graft intimal hyperplasia in nonhuman primates. J. Thorac. Cardiovasc. Surg. 136(3), 717–725 (2008).
   PubMed Web of Science ®Google Scholar
• Ibrahim IM, Sussman B, Dardik I et al. Adjunctive arteriovenous fistula with tibial and peroneal reconstruction for limb salvage. Am. J. Surg. 140(2), 246–251 (1980).
   Google Scholar
• Dardik H, Silvestri F, Alasio T et al. Improved method to create the common ostium variant of the distal arteriovenous fistula for enhancing crural prosthetic graft patency. J. Vasc. Surg. 24(2), 240–248 (1996).
   PubMed Web of Science ®Google Scholar
• Dardik H, Sussman B, Ibrahim IM et al. Distal arteriovenous fistula as an adjunct to maintaining arterial and graft patency for limb salvage. Surgery 94(3), 478–486 (1983).
   Google Scholar
• Miller N, Dardik H, Wolodiger F, Sussman B, Kahn M, Ibrahim IM. Dual function of the distal arteriovenous fistula for maintenance of arterial and venous prosthetic graft patency in the lower extremity. J. Cardiovasc. Surg. 30(2), 225–229 (1989).
   Google Scholar
• Kreienberg PB, Darling RC 3rd, Chang BB, Paty PS, Lloyd WE, Shah DM. Adjunctive techniques to improve patency of distal prosthetic bypass grafts: polytetrafluoroethylene with remote arteriovenous fistulae versus vein cuffs. J. Vasc. Surg. 31(4), 696–701 (2000).
   Google Scholar
• Fuster V, Chesebro JH. Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. Circulation 73(2), 227–232 (1986).
   Google Scholar
• Dixon BS, Beck GJ, Vazquez MA et al.; DAC Study Group. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N. Engl. J. Med. 360(21), 2191–2201 (2009).
   PubMed Web of Science ®Google Scholar
• Dember LM, Beck GJ, Allon M et al.; Dialysis Access Consortium Study Group. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 299(18), 2164–2171 (2008).
   PubMed Web of Science ®Google Scholar
• Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet 355(9201), 346–351 (2000).
   PubMed Web of Science ®Google Scholar
• Anand SS. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (the Dutch Bypass Oral anticoagulants or Aspirin study). Lancet 355, 346–351 (2000).
   Google Scholar
• Ariesen MJ, Tangelder MJ, Lawson JA, Eikelboom BC, Grobbee DE, Algra A; Dutch Bypass Oral Anticoagulants or Aspirin Study Group. Risk of major haemorrhage in patients after infrainguinal venous bypass surgery: therapeutic consequences? The Dutch BOA (Bypass Oral Anticoagulants or Aspirin) Study. Eur. J. Vasc. Endovasc. Surg. 30(2), 154–159 (2005).
   Google Scholar
• Koppensteiner R, Spring S, Amann-Vesti BR et al. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial. J. Vasc. Surg. 44(6), 1247–1253 (2006).
   Google Scholar
• Eriksen UH, Amtorp O, Bagger JP et al. Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty. Am. Heart J. 130(1), 1–8 (1995).
   PubMed Web of Science ®Google Scholar
• Katayama T, Ueba H, Tsuboi K et al. Reduction of neointimal hyperplasia after coronary stenting by pioglitazone in nondiabetic patients with metabolic syndrome. Am. Heart J. 153(5), 762.e1–762.e7 (2007).
   Google Scholar
• Kimura S, Egashira K, Nakano K et al. Local delivery of imatinib mesylate (STI571)-incorporated nanoparticle ex vivo suppresses vein graft neointima formation. Circulation 118(14 Suppl.), S65–S70 (2008).
   PubMed Web of Science ®Google Scholar
• Yang J, Zeng Y, Li Y et al. Intravascular site-specific delivery of a therapeutic antisense for the inhibition of restenosis. Eur. J. Pharm. Sci. 35(5), 427–434 (2008).
   PubMed Web of Science ®Google Scholar
• Kritz AB, Yu J, Wright PL et al. In vivo modulation of Nogo-B attenuates neointima formation. Mol. Ther. 16(11), 1798–1804 (2008).
   Google Scholar
• de Graaf R, Kloppenburg G, Tintu A et al. The new immunosuppressive agent FK778 attenuates neointima formation in an experimental venous bypass graft model. Vascul. Pharmacol. 50(3–4), 83–88 (2009).
   Google Scholar
• Hata JA, Petrofski JA, Schroder JN et al. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts. J. Thorac. Cardiovasc. Surg. 129(6), 1405–1413 (2005).
   PubMedGoogle Scholar
• Ni J, Waldman A, Khachigian LM. c-Jun regulates shear- and injury-inducible Egr-1 expression, vein graft stenosis after autologous end-to-side transplantation in rabbits, and intimal hyperplasia in human saphenous veins. J. Biol. Chem. 285(6), 4038–4048 (2010).
   PubMed Web of Science ®Google Scholar
• Daenens K, Schepers S, Fourneau I, Houthoofd S, Nevelsteen A. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results. J. Vasc. Surg. 49(5), 1210–1216 (2009).
   Google Scholar
• Davidson I, Hackerman C, Kapadia A, Minhajuddib A. Heparin bonded hemodialysis e-PTFE grafts result in 20% clot free survival benefit. J. Vasc. Access 10(3), 153–156 (2009).
   Google Scholar
• Armstrong J, Gunn J, Arnold N et al. Angiopeptin-eluting stents: observations in human vessels and pig coronary arteries. J. Invasive Cardiol. 14(5), 230–238 (2002).
   Google Scholar
• Kwok OH, Chow WH, Law TC et al. First human experience with angiopeptin-eluting stent: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Catheter Cardiovasc. Interv. 66(4), 541–546 (2005).
   PubMed Web of Science ®Google Scholar
• Kibbe MR, Tzeng E, Gleixner SL et al. Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia. J. Vasc. Surg. 34(1), 156–165 (2001).
   PubMed Web of Science ®Google Scholar
• Jewell CM, Fuchs SM, Flessner RM, Raines RT, Lynn DM. Multilayered films fabricated from an oligoarginine-conjugated protein promote efficient surface-mediated protein transduction. Biomacromolecules 8(3), 857–863 (2007).
   Google Scholar
• Bowden RG, Wilson RL, Gentile M, Ounpraseuth S, Moore P, Leutholtz BC. Effects of omega-3 fatty acid supplementation on vascular access thrombosis in polytetrafluorethylene grafts. J. Ren. Nutr. 17(2), 126–131 (2007).
   Google Scholar
• Hiltunen MO, Laitinen M, Turunen MP et al. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 102(18), 2262–2268 (2000).
   PubMed Web of Science ®Google Scholar
• Pintucci G, Saunders PC, Gulkarov I et al. Anti-proliferative and anti-inflammatory effects of topical MAPK inhibition in arterialized vein grafts. FASEB J. 20(2), 398–400 (2006).
   Google Scholar
• Hu Y, Zou Y, Dietrich H, Wick G, Xu Q. Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin. Circulation 100(8), 861–868 (1999).
   PubMed Web of Science ®Google Scholar
• George SJ, Wan S, Hu J, MacDonald R, Johnson JL, Baker AH. Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy. Circulation 124(11 Suppl.), S135–S142 (2011).
   Web of Science ®Google Scholar
• Thomas AC, Wyatt MJ, Newby AC. Reduction of early vein graft thrombosis by tissue plasminogen activator gene transfer. Thromb. Haemost. 102(1), 145–152 (2009).
   Google Scholar
• Zheng H, Xue S, Lian F, Wang YY. A novel promising therapy for vein graft restenosis: overexpressed Nogo-B induces vascular smooth muscle cell apoptosis by activation of the JNK/p38 MAPK signaling pathway. Med. Hypotheses 77(2), 278–281 (2011).
   Google Scholar
• Conte MS, Bandyk DF, Clowes AW et al.; PREVENT III Investigators. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J. Vasc. Surg. 43(4), 742–751; discussion 751 (2006).
   PubMed Web of Science ®Google Scholar
• Alexander JH, Hafley G, Harrington RA et al.; PREVENT IV Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 294(19), 2446–2454 (2005).
   PubMed Web of Science ®Google Scholar
• Du D, Chang S, Chen B, Zhou H, Chen ZK. Adenovirus-mediated heme oxygenase transfer inhibits graft arteriosclerosis in rat aortic transplants. Transplant. Proc. 39(10), 3446–3448 (2007).
   Google Scholar
• Durante W, Lin CC. HOming in on arteriovenous fistula survival. Kidney Int. 74(1), 9–11 (2008).
   Google Scholar
• Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S. Endothelial progenitor cells: new hope for a broken heart. Circulation 107(24), 3093–3100 (2003).
   PubMed Web of Science ®Google Scholar
• Dardik A, Liu A, Ballermann BJ. Chronic in vitro shear stress stimulates endothelial cell retention on prosthetic vascular grafts and reduces subsequent in vivo neointimal thickness. J. Vasc. Surg. 29(1), 157–167 (1999).
   PubMed Web of Science ®Google Scholar
• Meinhart JG, Deutsch M, Fischlein T, Howanietz N, Fröschl A, Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann. Thorac. Surg. 71(Suppl. 5), S327–S331 (2001).
   PubMed Web of Science ®Google Scholar
• Nugent HM, Sjin RT, White D et al. Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts. J. Vasc. Surg. 46(3), 548–556 (2007).
   Google Scholar
• Nugent HM, Groothuis A, Seifert P et al. Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. J. Vasc. Res. 39(6), 524–533 (2002).
   Google Scholar
• Conte MS, Nugent HM, Gaccione P, Guleria I, Roy-Chaudhury P, Lawson JH. Multicenter Phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study. J. Vasc. Surg. 50(6), 1359–1368.e1 (2009).
   Google Scholar
• Taite LJ, Yang P, Jun HW, West JL. Nitric oxide-releasing polyurethane–PEG copolymer containing the YIGSR peptide promotes endothelialization with decreased platelet adhesion. J. Biomed. Mater. Res. B Appl. Biomater. 84(1), 108–116 (2008).
   PubMed Web of Science ®Google Scholar
• Kapadia MR, Chow LW, Tsihlis ND et al. Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. J. Vasc. Surg. 47(1), 173–182 (2008).
   PubMed Web of Science ®Google Scholar
• Wang J, Liu K, Shen L, Wu H, Jing H. Small interfering RNA to c-myc inhibits vein graft restenosis in a rat vein graft model. J. Surg. Res. 169(1), e85–e91 (2011).
   PubMed Web of Science ®Google Scholar
• Karper JC, de Vries MR, van den Brand BT et al. Toll-like receptor 4 is involved in human and mouse vein graft remodeling, and local gene silencing reduces vein graft disease in hypercholesterolemic APOE*3Leiden mice. Arterioscler. Thromb. Vasc. Biol. 31(5), 1033–1040 (2011).
   Google Scholar
• Kohler TR, Toleikis PM, Gravett DM, Avelar RL. Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap paclitaxel-eluting mesh. J. Vasc. Surg. 45(5), 1029–1037; discussion 1037 (2007).
   Google Scholar